| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9393547 | Revista Española de Medicina Nuclear | 2005 | 9 Pages |
Abstract
These results suggest that PET-FDG seems to be a promising tool in the follow-up of thyroid cancer and should be considered in patients suffering from differentiated thyroid cancer with suspected recurrence and/or metastases by elevated thyroglobulin levels, and negative I-131 whole body scans. PET-FDG might be more useful at hTg levels > 10Â ng/ml.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
J.V. Ruiz Franco-Baux, I. Borrego Dorado, P. Gómez Camarero, J.R. RodrÃguez RodrÃguez, R.J. Vázquez Albertino, E. Navarro González, R. Astorga Jiménez,